Cita APA (7a ed.)

H, X., JF, Z., & Q, L. (2021). Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores. Dove Medical Press.

Cita Chicago Style (17a ed.)

H, Xie, Zhang JF, y Li Q. Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores. Dove Medical Press, 2021.

Cita MLA (8a ed.)

H, Xie, et al. Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores. Dove Medical Press, 2021.